Managing alcohol withdrawal in the elderly

Drugs and Aging

Volumn 14, Issue 6, 1999, Pages 409-425

  Kraemer, Kevin L ^a   Conigliaro, Joseph ^a,b   Saitz, Richard ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; CLONIDINE; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; HALOPERIDOL; LORAZEPAM; MAGNESIUM SULFATE; NORDAZEPAM; OXAZEPAM; PARALDEHYDE; PRAZEPAM; PROPRANOLOL; THIAMINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DISEASE SEVERITY; DRUG EFFICACY; DRUG ELIMINATION; HEMOLYSIS; HOSPITALIZATION; HUMAN; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PATHOPHYSIOLOGY; PATIENT MONITORING; PHLEBITIS; PRIORITY JOURNAL; REVIEW; SEDATION; SEIZURE; SOCIAL SUPPORT; TACHYCARDIA; TREATMENT PLANNING;

AGE FACTORS; AGED; ALCOHOLISM; CLINICAL TRIALS; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0033009175     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199914060-00002     Document Type: Review

References (177)

1. 1. Reid MC, Anderson PA. Geriatric substance use disorders. Med Clin North Am 1997; 81 (4): 999-1016
2. 2. Fink A, Hays RD, Moore AA, et al. Alcohol-related problems in older persons. Determinants, consequences, and screening. Arch Intern Med 1996; 156 (11): 1150-6
3. 3. Council on Scientific Affairs. Alcoholism in the elderly: council report. JAMA 1996; 275 (10): 797-801
4. 4. Schuckit MA. Clinical review of alcohol, alcoholism, and the elderly patient. J Clin Psychiatry 1982; 43: 396-9
5. 5. Atkinson RM. Aging and alcohol use disorders: diagnostic issues in the elderly. Int Psychogeriatr 1990; 2: 55-72
6. 6. Finlayson RE, Hurt RD, Davis Jr LJ, et al. Alcoholism in elderly persons: a study of the psychiatric and psychosocial features of 216 inpatients. Mayo Clin Proc 1988; 63 (8): 761-8
7. 7. Beresford TP, Beresford T, Gomberg E, editors. Alcohol and aging. New York: Oxford University Press, 1995
8. 8. Hurt RD, Finlayson RE, Morse RM, et al. Alcoholism in elderly persons: medical aspects and prognosis of 216 inpatients. Mayo Clin Proc 1988; 63 (8): 753-60
9. 9. Grant BF. Alcohol consumption, alcohol abuse and alcohol dependence: the United States as an example. Addiction 1994; 89 (11): 1357-65
10. 10. Williams GD, DeBakey SF. Changes in levels of alcohol consumption: United States, 1983-1988. Br J Addict 1992; 87: 643-8
11. 11. Adams WL, Magruder-Habib K, Trued S, et al. Alcohol abuse in elderly emergency department patients. J Am Geriatr Soc 1992; 40 (12): 1236-40
12. 12. Buchsbaum DG, Buchanan RG, Lawton MJ, et al. Alcohol consumption patterns in a primary care population. Alcohol Alcohol 1991; 26 (2): 215-20
13. 13. Curtis JR, Geller G, Stokes EJ, et al. Characteristics, diagnosis, and treatment of alcoholism in elderly patients. J Am Geriatr Soc 1989; 37 (4): 310-6
14. 14. Liberto JG, Oslin DW, Ruskin PE. Alcoholism in older persons: a review of the literature. Hosp Community Psychiatry 1992; 43 (10): 975-84
15. 15. Magruder-Habib K, Saltz CC, Barron PM. Age-related patterns of alcoholism among veterans in ambulatory care. Hosp Community Psychiatry 1986; 37 (12): 1251-5
16. 16. Mangion DM, Platt JS, Syam V. Alcohol and acute medical admission of elderly people. Age Ageing 1992; 21 (5): 362-7
17. 17. Schuckit MA, Miller PL. Alcoholism in elderly men: a survey of a general medical ward. Ann N Y Acad Sci 1975; 275: 558-71
18. 18. Simon A, Epstein LJ, Reynolds L. Alcoholism in the geriatric mentally ill. Geriatrics 1968; 23 (10): 125-31
19. 19. Gaitz CM, Baer PE. Characteristics of elderly persons with alcoholism. Arch Gen Psychiatry 1971; 24: 372-8
20. 20. Tabisz E, Badger M, Meatherall R, et al. Identification of chemical abuse in the elderly admitted to emergency rooms. Clin Gerontol 1991; 11: 27-38
21. 21. Adams WL, Yuan Z, Barboriak JJ, et al. Alcohol-related hospitalizations of elderly people: prevalence and geographic variation in the United States [published erratum appears in JAMA 1993 Nov 3; 270 (17): 2055]. JAMA 1993; 270 (10): 1222-5
22. 22. Kraemer KL, Mayo-Smith MF, Calkins DR. Impact of age on the severity, course, and complications of alcohol withdrawal. Arch Intern Med 1997; 157 (19): 2234-41
23. 23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
24. 24. Whitfield CL, Thompson G, Lamb A, et al. Detoxification of 1,024 alcoholic patients without psychoactive drugs. JAMA 1978; 239: 1409-10
25. 25. Benzer DG. Quantification of the alcohol withdrawal syndrome in 487 alcoholic patients. J Subst Abuse Treat 1990; 7 (2): 117-23
26. 26. Liskow BI, Rinck C, Campbell J, et al. Alcohol withdrawal in the elderly. J Stud Alcohol 1989; 50 (5): 414-21
27. 27. Brower KJ, Mudd S, Blow FC, et al. Severity and treatment of alcohol withdrawal in elderly versus younger patients. Alcohol Clin Exp Res 1994; 18 (1): 196-201
28. 28. Linnoila M. Alcohol withdrawal and noradrenergic function. Ann Intern Med 1987; 107: 875-89
29. 29. Sellers EM, Zilm DH, Degani NC. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 1977; 38 (11): 2096-108
30. 30. Worner TM. Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am J Drug Alcohol Abuse 1994; 20 (1): 115-24
31. 31. Kraus ML, Gottlieb LD, Horwitz RI, et al. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313 (15): 905-9
32. 32. Zilm DH, Jacob MS, MacLeod SM, et al. Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcohol Clin Exp Res 1980; 4 (4): 400-5
33. 33. Bjorkqvist SE. Clonidine in alcohol withdrawal. Acta Psychiatr Scand 1975; 52 (4): 256-63
34. 34. Wilkins AJ, Jenkins WJ, Steiner JA. Efficacy of clonidine in treatment of the alcohol withdrawal state. Psychopharmacology 1983; 81 (1): 78-80
35. 35. Manhem P, Nilsson LH, Moberg AL, et al. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcohol Clin Exp Res 1985; 9 (3): 238-43
36. 36. Baumgartner GR, Rowen RC. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 147 (7): 1223-6
37. 37. Cushman Jr P, Sowers JR. Alcohol withdrawal syndrome: clinical and hormonal responses 10 alpha 2-adrenergic agonist treatment. Alcohol Clin Exp Res 1989; 13 (3): 361-4
38. 38. Robinson BJ, Robinson GM, Maling TJ, et al. Is clonidine useful in the treatment of alcohol withdrawal? Alcohol Clin Exp Res 1989; 13 (1): 95-8
39. 39. Baumgartner GR, Rowen RC. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 1991; 84 (3): 312-21
40. 40. Ticku MK. Alcohol and GABA-benzodiazepine receptor function. Ann Med 1990; 22: 241-6
41. 41. Gorelick DA. Recent developments in alcoholism: pharmacological treatment. Recent Dev Alcohol 1993; 11: 413-27
42. 42. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry 1995; 152 (3): 332-40
43. 43. Freund G, Anderson KJ. Glutamate receptors in the frontal cortex of alcoholics. Alcohol Clin Exp Res 1996; 20: 1165-72
44. 44 Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 1978; 133: 1-14
45. 45. Lechtenberg R, Worner TM. Seizure risk with recurrent alcohol detoxification. Arch Neurol 1990; 47; 535-8
46. 46. Brown ME, Anton RF, Malcolm R, et al. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry 1988; 23 (5): 507-14
47. 47. Booth BM, Blow FC. The kindling hypothesis: further evidence from a US national study of alcoholic men. Alcohol Alcohol 1993; 28 (5): 593-8
48. 48. Lechtenberg R, Worner TM. Relative kindling effect of detoxification and non-detoxification admissions in alcoholics. Alcohol Alcohol 1991; 26 (2): 221-5
49. 49. Foy A, Kay J, Taylor A. The course of alcohol withdrawal in a general hospital. Q J Med 1997; 90 (4): 253-61
50. 50. Isbell H, Fraser HF, Wikler A, et al. An experimental study of the etiology of 'rum fits' and delirium tremens. Q J Stud Alcohol 1955; 16: 1-33
51. 51. Pristach CA, Smith CM, Whitney RB. Alcohol withdrawal syndromes: prediction from detailed medical and drinking histories. Drug Alcohol Depend 1983; 11 (2): 177-99
52. 52. Ferguson JA, Suelzer CJ, Eckert GJ, et al. Risk factors for delirium tremens development. J Gen Intern Med 1996; 11 (7): 410-4
53. 53. Schuckit MA, Tipp JE, Reich T, et al. The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 1995; 90: 1335-47
54. 54. Wetterling T, Kanitz RD, Veltrup C, et al. Clinical predictors of alcohol withdrawal delirium. Alcohol Clin Exp Res 1994; 18 (5): 1100-2
55. 55. Vinson DC, Menezes M. Admission alcohol level: a predictor of the course of alcohol withdrawal. J Fam Pract 1991; 33 (2): 161-7
56. 56. Foy A, March S, Drinkwater V. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res 1988; 12 (3): 360-4
57. 57. Victor M, Adams RD. The effect of alcohol on the nervous system. Res Publ Assoc Res Nerv Ment Dis 1953; 32: 526-73
58. 58. Morton AW, Laird LK, Crane DF, et al. A prediction model for identifying alcohol withdrawal seizures. Am J Drug Alcohol Abuse 1994; 20: 75-86
59. 59. Metcalfe P, Sobers M, Dewey M, The Windsor clinic alcohol withdrawal assessment scale (WCAWAS): investigation of factors associated with complicated withdrawals. Alcohol Alcohol 1995; 30 (3): 367-72
60. 60. Fiellin DA, Samet JH, O'Connor PC, Reducing bias in observational research on alcohol withdrawal syndrome. Subst Abuse 1998; 19: 23-31
61. 61. Shaw JM, Kolesar GS, Sellers EM, et al. Development of optimal treatment tactics for alcohol withdrawal: I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1981; 1 (6): 382-7
62. 62. Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84 (11): 1353-7
63. 63. Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale. J Clin Psychopharmacol 1991; 11 (5); 291-5
64. 64. Salloum IM, Cornelius JR, Daley DC, et al. The utility of diazepam loading in the treatment of alcohol withdrawal among psychiatric inpatients. Psychopharmacol Bull 1995; 31 (2): 305-10
65. 65. Wartenberg AA, Nirenberg TD, Liepman MR, et al. Detoxification of alcoholics: improving care by symptom-triggered sedation. Alcohol Clin Exp Res 1990; 14 (1): 71-5
66. 66. Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA 1994; 272 (7): 519-23
67. 67. Hayashida M, Alterman Al, McLellan AT, et al. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med 1989; 320 (6): 358-65
68. 68. Sparadeo FR, Zwick WR, Ruggiero SD, et al. Evaluation of a social-setting detoxication program. J Stud Alcohol 1982; 43 (11): 1124-36
69. 69. O'Connor PG, Gottlieb LD, Kraus ML, et al. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. J Gen Intern Med 1991; 6 (4): 312-6
70. 70. Feldman DJ, Pattison EM, Sobell LC, et al. Outpatient alcohol detoxification: initial findings on 564 patients. Am J Psychiatry 1975; 132: 407-12
71. 71. Stockwell T, Bolt L, Milner I, et al. Home detoxification from alcohol: its safety and efficacy in comparison with inpatient care. Alcohol Alcohol 1991; 26 (5-6): 645-50
72. 72. Evans DJ, Street SD, Lynch DJ. Alcohol withdrawal at home: pilot project for frail elderly people. Can Fam Physician 1996; 42: 937-45
73. 73. Naranjo CA, Sellers EM, Chater K, et al. Nonpharmacologic intervention in acute alcohol withdrawal. Clin Pharmacol Ther 1983; 34 (2): 214-9
74. 74. Sellers EM, Naranjo CA, Harrison M, et al. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34 (6): 822-6
75. 75. Levkoff SE, Marcantonio ER. Delirium: a major diagnostic and therapeutic challenge for clinicians caring for the elderly. Compr Ther 1994; 20: 550-7
76. 76. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1997; 278 (2): 144-51
77. 77. Saitz R, O'Malley SS. Pharmacotherapies for alcohol abuse: withdrawal and treatment. Med Clin North Am 1997; 81 (4): 881-907
78. 78. Sellers EM, Kalant H. Alcohol intoxication and withdrawal. N Eng J Med 1976; 294: 757-62
79. 79. Turner RC, Lichstein PR, Peden Jr JG, et al. Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment. J Gen Intern Med 1989; 4 (5): 432-44
80. 80. Saitz R, Friedman LS, Mayo-Smith MF. Alcohol withdrawal: a nationwide survey of inpatient treatment practices. J Gen Intern Med 1995; 10 (9): 479-87
81. 81. Institute of Medicine. Prevention and treatment of alcohol problems. Washington, DC: National Academy Press, 1990: 268
82. 82. Rosenfeld JE, Bizzoco DH. A controlled study of alcohol withdrawal. Q J Stud Alcohol 1961; 1: 77-84
83. 83. Sereny G, Kalant H. Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol withdrawal syndrome. BMJ 1965; 1: 92-7
84. 84. Kaim SC, Klett CJ, Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry 1969; 125 (12): 1640-6
85. 85. Greenblatt DJ, Shader RI, Abernethy DR. Drug therapy: current status of benzodiazepines. N Engl J Med 1983; 309 (7): 410-6
86. 86. Peppers MP. Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease. Pharmacotherapy 1996; 16 (1): 49-57
87. 87. Meyer BR. Benzodiazepines in the elderly. Med Clin North Am 1982; 66 (5): 1017-35
88. 88. American Psychiatric Association. Task force on benzodiazepine dependency: benzodiazepine dependence, toxicity and abuse. Washington, DC: American Psychiatric Association, 1990
89. 89. Shader RI, Greenblatt DJ, Harmatz JS, et al. Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J Clin Pharmacol 1977; 17: 709-18
90. 90. MacLeod SM, Giles HG, Bengert B, et al. Age and gender related differences in diazepam pharmacokinetics. J Clin Pharmacol 1979; 19: 15-9
91. 91. Greenblatt DJ, Allen MD, Harmatz JS, et al. Diazepam disposition determinants. Clin Pharmacol Ther 1980; 27: 301-12
92. 92. Roberts RK, Wilkinson GR, Branch RA, et al. Effects of age and parenchymal liver disease on the disposition of chlordiazepoxide (librium). Gastroenterology 1978; 75: 479-85
93. 93. Macklon AF, Barton M, James O, et al. The effect of age on the pharmacokinetics of diazepam. Clin Sci 1980; 59: 479-83
94. 94. Allen MD, Greenblatt DJ, Harmatz JS, et al. Desmethyldiazepam kinetics in the elderly after prazepam. Clin Pharmacol Ther 1980; 28: 196-202
95. 95. Klotz U, Muller-Seydlitz P. Altered elimination of desmethyldiazepam in the elderly. Br J Clin Pharmacol 1979; 7: 119-20
96. 96. Greenblatt DJ, Allen MD, Locniskar A, et al. Lorazepam kinetics in the elderly. Clin Pharmacol Ther 1979; 26: 103-13
97. 97. Kraus JW, Desmond PU, Marshall JP, et al. Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther 1978; 24: 411-9
98. 98. Murray TG, Chiang ST, Koepke HH, et al. Renal disease, age, and oxazepam kinetics. Clin Pharmacol Ther 1981; 30: 805-9
99. 99. Greenblatt DJ, Divott M, Harmatz JS, et al. Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther 1980; 215: 86-91
100. 100. Salzman C, Shader RI, Greenblatt DJ, et al. Long versus short half-life benzodiazepines in the elderly: kinetics and clinical effects of diazepam and oxazepam. Arch Gen Psychiatry 1983; 40: 293-7
101. 101. Castledon CM, George CF, Marcer D, et al. Increased sensitivity to nitrazepam in old age. BMJ 1977; 1: 10-2
102. 102. Healy M, Pickens R, Meisch K, et al. Effects of clorazapate, diazepam, lorazepam, and placebo on human memory. J Clin Psychiatry 1983; 44: 436-9
103. 103. Gottshalk L. Affective and cognitive problems with benzodiazepines. J Clin Psychopharmacol 1988; 8: 223-5
104. 104. Reidenherg MM, Levy M, Warner H, et al. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther 1978; 23: 371-4
105. 105. Giles HG, MacLeod SM, Wright JR, et al. Influence of age and previous use on diazepam dosage required for endoscopy. Can Med Assoc J 1978; 118: 513-4
106. 106. Ritson B, Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. Drug Alcohol Depend 1986; 18 (4): 329-34
107. 107. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med 1993; 328 (19): 1398-405
108. 108. Wilson A, Vulcano BA. Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome. Alcohol Clin Exp Res 1985; 9 (1): 23-7
109. 109. Mayo-Smith MF, Bernard D, Late-onset seizures in alcohol withdrawal. Alcohol Clin Exp Res 1995; 19 (3): 656-9
110. 110. Solomon K, Manepalli J, Ireland GA, et al. Alcoholism and prescription drug abuse in the elderly: St Louis University grand rounds [clinical conference]. J Am Geriatric Soc 1993; 41 (1): 57-69
111. 111. Hill A, Williams D. Hazards associated with the use of benzodiazepines in alcohol detoxification. J Subst Abuse Treat 1993; 10 (5): 449-51
112. 112. Bird RD, Makela EH. Alcohol withdrawal: what is the benzodiazepine of choice? Ann Pharmacother 1994; 28 (1): 67-71
113. 113. Ayd FJ. Oxazepam: update 1989. Int Clin Psychopharmacol 1991; 5: 1-15
114. 114. Heinala P, Piepponen T, Heikkinen H, Diazepam loading in alcohol withdrawal: clinical pharmacokinetics. Int J Clin Pharmacol Ther Toxicol 1990; 28 (5): 211-7
115. 115. Wadstein J, Manhem P, Nilsson LH, et al. Clonidine versus chlormethiazole in alcohol withdrawal. Acta Psychiatr Scand 1986; 327 Suppl.: 144-8
116. 116. Jacob MS, Zilm DH, MacLeod SM, et al. Propranolol-associated confused states during alcohol withdrawal. J Clin Psychopharmacol 1983; 3 (3): 185-7
117. 117. Kuhr BM. Prolonged delirium with propanolol. J Clin Psychiatry 1979; 40 (4): 198-9
118. 118. Zechnich RJ. Beta blockers can obscure diagnosis of delirium tremens [letter]. Lancet 1982; 1 (8280): 1071-2
119. 119. Kramp P, Rafaelsen OJ. Delirium tremens: a double-blind comparison of diazepam and barbital treatment. Acta Psychiatr Scand 1978; 58 (2): 174-90
120. 120. Bemus I, Dickinson RG, Hooper WD, et al. Anticonvulsant therapy in aged patients: clinical pharmacokinetic considerations. Drugs Aging 1997; 10: 278-89
121. 121. Mendelson JH, Ogata M, Mello NK. Effects of alcohol ingestion and withdrawal on magnesium stales of alcoholics: clinical and experimental findings. Ann N Y Acad Sci 1969; 162: 918-33
122. 122. Wacker WEC, Parisi AF. Magnesium metabolism. N Eng J Med 1968; 278: 658-63
123. 123. Dirks JH. The kidney and magnesium regulation. Kidney Int 1983; 23: 771-7
124. 124. Kramp P, Hemmingsen R, Rafaelson OJ. Magnesium concentrations in blood and cerebrospinal fluid during delirium tremens. Psychiatry Res 1979; 1 (2): 161-71
125. 125. Ragland G. Electrolyte abnormalities in the alcoholic patient. Emerg Med Clin North Am 1990; 8 (4): 761-73
126. 126. Wilson A, Vulcano BA. A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcohol Clin Exp Res 1984; 8: 542-5
127. 127. Denison H, Jern S, Jagenhurg R, et al. Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal. Br Heart J 1994; 72 (6): 554-60
128. 128. Victor M, Adams RC, Collins GH. The Wernicke-Korsakoff syndrome and related neurological disorders due to alcoholism and malnutrition. Philadelphia: FA Davis, 1989
129. 129. Harper C. Wernicke's encephalopathy: a more common disease than realised: a neuropathological study of 51 cases. J Neurol Neurosurg Psychiatry 1979; 42 (3): 226-31
130. 130. Bjorkqvist SE, Isohanni M, Makela R, et al. Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre double-blind comparison with placebo. Acta Psychiatr Scand 1976; 53 (5): 333-42
131. 131. Flygenring J, Hansen J, Holst B, et al. Treatment of alcohol withdrawal symptoms in hospitalized patients: a randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal). Acta Psychiatr Scand 1984; 69 (5): 398-408
132. 132. Malcolm R, Ballenger JC, Sturgis ET, et al. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146 (5): 617-21
133. 133. Stuppaeck CH, Pycha R, Miller C, et al. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 1992; 27 (2): 153-8
134. 134. Chu NS. Carbamazepine: prevention of alcohol withdrawal seizures. Neurology 1979; 29 (10): 1397-401
135. 135. Racine R, Kindling: the first decade. Neurosurgery 1978; 3 (2): 234-52
136. 136. Bowman EH, Thimann J. Treatment of alcoholism in the subacute stage: a study of three active agents. Dis Nerv Syst 1966; 27 (5): 342-6
137. 137. Palestine ML, Alatorre E. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide. Curr Ther Res Clin Exp 1976; 20 (3): 289-99
138. 138. Thomas DW, Freedman DX. Treatment of the alcohol withdrawal syndrome: comparison of promazine and paraldehyde. JAMA 1964; 188:244-6
139. 139. Chambers JF, Schultz JD. Double-blind study of three drugs in the treatment of acute alcoholic states. Q J Stud Alcohol 1965; 26: 10-18
140. 140. Blum K, Eubanks JD, Wallace JE, et al. Enhancement of alcohol withdrawal convulsions in mice by haloperidol. Clin Toxicol 1976; 9: 427-34
141. 141. Thompson WL, Johnson AD, Maddrey WL. Diazepam and paraldehyde for treatment of severe delirium tremens: a controlled trial. Ann Intern Med 1975; 82 (2): 175-80
142. 142. Golbert TM, Sanz, CJ, Rose HD, et al. Comparative evaluation of treatments of alcohol withdrawal syndromes. JAMA 1967; 201 (2); 99-102
143. 143. Morgan MY. The management of alcohol withdrawal using chlormethiazolc. Alcohol Alcohol 1995; 30 (6): 771-4
144. 144. Fulton B, Park GR. Intravenous chlormethiazole. Br J Hosp Med 1992; 48 (11): 742-7
145. 145. Spies CD, Dubisz N, Funk W, et al. Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection. Br J Anaesth 1995; 75 (6): 734-9
146. 146. Gillman MA, Lichtigfeld FJ. The drug management of severe alcohol withdrawal syndrome. Postgrad Med J 1991; 66: 1005-9
147. 147. Tubridy P. Alprazolam versus chlormethiazole in acute alcohol withdrawal. Br J Addict 1988; 83 (5): 581-5
148. 148. Palsson A. The efficacy of early chlormethiazole medication in the prevention of delirium tremens. Acta Psychiatr Scand 1986; 329 Suppl.: 140-5
149. 149. Burroughs AK, Morgan MY, Sherlock S. Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms. Alcohol Alcohol 1985; 20 (3): 263-71
150. 150. Lapierre YD, Bulmer DR, Oyewumi LK, et al. Comparison of chlormethiazole and chlordiazepoxide in the treatment of acute alcohol withdrawal. Neuropsychobiology 1983; 10: 127-30
151. 151. Frecker RC, Shaw JM, Zilm DH, et al. Nonpharmacological supportive care compared to chlormethiazole infusion in the management of severe acute alcohol withdrawal. J Clin Psychopharmacol 1982; 2 (4): 277-80
152. 152. Ritola E, Malinen L. A double-blind comparison of carbamazepine and chlormethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981; 64: 254-9
153. 153. Madden JS, Jones D, Frisch EP, Chlormethiazole and trifluoperazine in alcohol withdrawal. Br J Psychiatry 1969; 115: 1191-2
154. 154. Harfst MJ, Greene JG, Lassae FG. Controlled trial comparing amobarbital and chlormethiazole in alcohol withdrawal symptoms. Q J Stud Alcohol 1967; 28: 641-8
155. 155. Glatt MM, George HR, Frisch EP. Evaluation of chlormethiazole in treatment for alcohol withdrawal syndrome. Acta Psychiatr Scand 1966; 192 Suppl.: 121-37
156. 156. Marcantonio ER, Goldman L, Mangione CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994; 271 (2): 134-9
157. 157. Inouye SK, Viscoli CM, Horwitz RI, et al. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119 (6): 474-81
158. 158. Jacobson SA. Delirium in the elderly. Psychiatr Clin North Am 1997; 20 (1): 91-110
159. 159. Hoey LL, Nahum A, Vance-Bryan K. A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal. Pharmacotherapy 1944; 14 (5): 579-85
160. 160. Cavanaugh SV. Psychiatric emergencies. Med Clin North Am 1986; 70 (5): 1185-202
161. 161. D'Onofrio G, Rathlev NK, Ulrich AS, et al. Lorazepam prevents recurrent alcohol-related seizures [abstract]. Acad emerg Med 1995; 2: 368
162. 162. Chance JF. Emergency department treatment of alcohol withdrawal seizures with phenytoin. Ann Emerg Med 1991; 20 (5): 520-2
163. 163. Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia 1993; 34 (6): 1033-7
164. 164. Alldredge BK, Lowenstein DH, Simon KP. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 1989; 87 (6): 645-8
165. 165. Sampliner R, Iber FL. Diphenylhydantoin control of alcohol withdrawal seizures: results of a controlled study. JAMA 1974; 230 (10): 1430-2
166. 166. Rathlev NK, D'Onofrio G, Fish SS, et al. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med 1994; 23 (3): 513-8
167. 167. Tavani CA. Perioperative psychiatric considerations in the elderly. Clin Geriatr Med 1990; 6 (3): 543-56
168. 168. Gower WE, Kersten H. Prevention of alcohol withdrawal symptoms in surgical patients. Surg Gynecol Obstet 1980; 151 (3): 382-4
169. 169. Craft PP, Foil MB, Cunningham PR, et al. Intravenous ethanol for alcohol detoxification in trauma patients. South Med J 1994; 87 (1): 47-54
170. 170. Hansbrough JF, Zapata-Sirvent RL, Carroll WJ, et al. Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients. Am J Surg 1984; 148 (2): 266-9
171. 171. Carlen PL, McAndrews MP, Weiss RT, et al. Alcohol-related dementia in the institutionalized elderly. Alcohol Clin Exp Res 1994; 18 (6): 1330-4
172. 172. Smith DM, Atkinson RM. Alcoholism and dementia. Int J Addict 1995; 30 (13-14): 1843-69
173. 173. Whitcup SM, Miller F. Unrecognized drug dependence in psychiatrically hospitalized elderly patients. J Am Geriatr Soc 1987; 35 (4): 297-301
174. 174. Kashner TM, Rodell DE, Ogden SR, et al. Outcomes and costs of two VA inpatient treatment programs for older alcoholic patients. Hosp Community Psychiatry 1992; 43 (10): 985-9
175. 175. Kofoed LL, Tolson RL, Atkinson RM, et al. Treatment compliance of older alcoholics: an elder-specific approach is superior to 'mainstreaming'. J Stud Alcohol 1987; 48 (1): 47-51
176. 176. Bien TH, Miller WR. Brief interventions for alcohol problems: a review. Addiction 1993; 88: 315-36
177. 177. Samet JH, Rollnick S, Barnes H. Beyond CAGE: a brief clinical approach after detection of substance abuse. Arch Intern Med 1996; 156: 2287-93